December 4, 2020 10:49 AM ESTUpdated December 8, 12:21 AM
Peer Review

GSK vet Antony Blanc signs on to be­come Cure­Vac's CBO and CCO; Chris Ca­bell out, Paul Streck in as Are­na Phar­ma­ceu­ti­cals CMO

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ En­thused about the Phase I da­ta for their Covid-19 mR­NA vac­cine and be­liev­ing they’ve cracked the cold-stor­age code in de­liv­er­ing them, Cure­Vac …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

TRENDING NOW

'Go ahead and do it': Top RFK Jr. deputy dares drug­mak­ers that might pull man­u­fac­tur­ing over new price pres­sure

New CBER chief Prasad is ready­ing 'mas­sive frame­work' around vac­cines, Makary says

The in­side sto­ry of the six-month sprint to cre­ate the first cus­tom CRISPR ther­a­py for one in­fant’s rare dis­ease

Eli Lil­ly turns to South Ko­re­an RNA edit­ing biotech for hear­ing loss in deal worth $1.3B

Bris­tol My­ers CEO says Amer­i­ca’s bio­phar­ma pole po­si­tion is not guar­an­teed

Ex­clu­sive: Drug com­pounder Em­pow­er was built on risky short­cuts, ex-em­ploy­ees and in­spec­tions al­lege

A service from the Financial Times